Erythrocyte-derived nano-probes functionalized with antibodies for targeted near infrared fluorescence imaging of cancer cells.
暂无分享,去创建一个
Vicente Nuñez | Bahman Anvari | Jenny T. Mac | Joshua M Burns | Vicente Nuñez | B. Anvari | V. Vullev | Valentine I Vullev | Jenny T Mac | Yadir A Guerrero | Yadir A. Guerrero
[1] V Ntziachristos,et al. Intraoperative near-infrared fluorescence imaging for sentinel lymph node detection in vulvar cancer: first clinical results. , 2011, Gynecologic oncology.
[2] T. Toyota,et al. Near-infrared-fluorescence imaging of lymph nodes by using liposomally formulated indocyanine green derivatives. , 2014, Bioorganic & medicinal chemistry.
[3] A. Vahrmeijer,et al. Dose optimization for near‐infrared fluorescence sentinel lymph node mapping in patients with melanoma , 2013, The British journal of dermatology.
[4] A. Welch,et al. A review of the optical properties of biological tissues , 1990 .
[5] Bahman Anvari,et al. Erythrocyte-derived photo-theranostic agents: hybrid nano-vesicles containing indocyanine green for near infrared imaging and therapeutic applications , 2013, Scientific Reports.
[6] Dennis E Discher,et al. Minimal " Self " Peptides That Inhibit Phagocytic Clearance and Enhance Delivery of Nanoparticles References and Notes , 2022 .
[7] B. Liu,et al. Hybrid polypeptide micelles loading indocyanine green for tumor imaging and photothermal effect study. , 2013, Biomacromolecules.
[8] C. Pirich,et al. Visualisation of the lymph node pathway in real time by laparoscopic radioisotope- and fluorescence-guided sentinel lymph node dissection in prostate cancer staging. , 2012, Urology.
[9] E. Scott,et al. Gadolinium-doped silica nanoparticles encapsulating indocyanine green for near infrared and magnetic resonance imaging. , 2012, Small.
[10] Vladimir Tolmachev,et al. Optimal specific radioactivity of anti-HER2 Affibody molecules enables discrimination between xenografts with high and low HER2 expression levels , 2011, European Journal of Nuclear Medicine and Molecular Imaging.
[11] Liangfang Zhang,et al. Erythrocyte‐Inspired Delivery Systems , 2012, Advanced healthcare materials.
[12] R. Spetzler,et al. Indocyanine Green Angiography in the Surgical Management of Cerebral Arteriovenous Malformations: Lessons Learned in 130 Consecutive Cases , 2014, Neurosurgery.
[13] B. Bax,et al. Survival of human carrier erythrocytes in vivo. , 1999, Clinical science.
[14] A. Santin,et al. HER2 Expression Beyond Breast Cancer: Therapeutic Implications for Gynecologic Malignancies , 2013, Molecular Diagnosis & Therapy.
[15] Ronnie H. Fang,et al. Lipid-insertion enables targeting functionalization of erythrocyte membrane-cloaked nanoparticles. , 2013, Nanoscale.
[16] Sheng-Wen Huang,et al. Indocyanine-green-embedded PEBBLEs as a contrast agent for photoacoustic imaging. , 2007, Journal of biomedical optics.
[17] Josephine C. Adams,et al. The evolution of thrombospondins and their ligand-binding activities. , 2010, Molecular biology and evolution.
[18] P. Oldenborg. CD47: A Cell Surface Glycoprotein Which Regulates Multiple Functions of Hematopoietic Cells in Health and Disease , 2013, ISRN hematology.
[19] O. Ganslandt,et al. Essentials in intraoperative indocyanine green videoangiography assessment for intracranial aneurysm surgery: conclusions from 295 consecutively clipped aneurysms and review of the literature. , 2014, Neurosurgical focus.
[20] R. Weissleder,et al. Near infrared fluorescence-based bacteriophage particles for ratiometric pH imaging. , 2008, Bioconjugate chemistry.
[21] Bahman Anvari,et al. Effects of nanoencapsulation and PEGylation on biodistribution of indocyanine green in healthy mice: quantitative fluorescence imaging and analysis of organs , 2013, International journal of nanomedicine.
[22] M. Epple,et al. Gold nanoparticles: dispersibility in biological media and cell-biological effect , 2010 .
[23] Antonella Antonelli,et al. Red blood cells as carriers of iron oxide-based contrast agents for diagnostic applications. , 2014, Journal of biomedical nanotechnology.
[24] J. M. Lanao,et al. Cell-based drug-delivery platforms. , 2012, Therapeutic delivery.
[25] W. Liu,et al. Red Blood Cell Membrane as a Biomimetic Nanocoating for Prolonged Circulation Time and Reduced Accelerated Blood Clearance. , 2015, Small.
[26] J. Frangioni. In vivo near-infrared fluorescence imaging. , 2003, Current opinion in chemical biology.
[27] B Gleich,et al. Nanoparticle encapsulation in red blood cells enables blood-pool magnetic particle imaging hours after injection , 2013, Physics in medicine and biology.
[28] J. C. Kraft,et al. Interactions of Indocyanine Green and Lipid in Enhancing Near-Infrared Fluorescence Properties: The Basis for Near-Infrared Imaging in Vivo , 2014, Biochemistry.
[29] Vladimir R Muzykantov,et al. Drug delivery by red blood cells: vascular carriers designed by mother nature , 2010, Expert opinion on drug delivery.
[30] C. Lagenaur,et al. Role of CD47 as a marker of self on red blood cells. , 2000, Science.
[31] L. Yannuzzi,et al. Indocyanine green angiography: a perspective on use in the clinical setting. , 2011, American journal of ophthalmology.
[32] H. Kantarjian,et al. Red blood cell-encapsulated L-asparaginase: potential therapy of patients with asparagine synthetase deficient acute myeloid leukemia. , 2013, Protein and peptide letters.
[33] Omid C Farokhzad,et al. Self-assembled targeted nanoparticles: evolution of technologies and bench to bedside translation. , 2011, Accounts of chemical research.
[34] N. Gjerdet,et al. Agglomeration and sedimentation of TiO2 nanoparticles in cell culture medium. , 2009, Colloids and surfaces. B, Biointerfaces.
[35] Michael Hünerbein,et al. ICG fluorescence-guided sentinel node biopsy for axillary nodal staging in breast cancer , 2010, Breast Cancer Research and Treatment.
[36] María Vallet-Regí,et al. The influence of proteins on the dispersability and cell-biological activity of silver nanoparticles , 2010 .
[37] Gianluca Damonte,et al. Erythrocyte-Mediated Delivery of Dexamethasone in Patients With Mild-to-Moderate Ulcerative Colitis, Refractory to Mesalamine: A Randomized, Controlled Study , 2008, The American Journal of Gastroenterology.
[38] D. Irvine,et al. Bio-inspired, bioengineered and biomimetic drug delivery carriers , 2011, Nature Reviews Drug Discovery.
[39] J. Karp,et al. Nanocarriers as an Emerging Platform for Cancer Therapy , 2022 .
[40] Milton V. Marshall,et al. Imaging of lymph flow in breast cancer patients after microdose administration of a near-infrared fluorophore: feasibility study. , 2008, Radiology.
[41] R. Flower,et al. Observation of erythrocyte dynamics in the retinal capillaries and choriocapillaris using ICG-loaded erythrocyte ghost cells. , 2008, Investigative ophthalmology & visual science.
[42] R. Kurzrock,et al. HER2 aberrations in cancer: implications for therapy. , 2014, Cancer treatment reviews.
[43] Bahman Anvari,et al. Stability assessment of indocyanine green within dextran-coated mesocapsules by absorbance spectroscopy. , 2007, Journal of biomedical optics.
[44] James H. Adair,et al. Calcium phosphate nanocomposite particles for in vitro imaging and encapsulated chemotherapeutic drug delivery to cancer cells. , 2008, Nano letters.
[45] S. Guichard,et al. Selective inhibition of HER2 inhibits AKT signal transduction and prolongs disease-free survival in a micrometastasis model of ovarian carcinoma. , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.
[46] Ronnie H. Fang,et al. Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform , 2011, Proceedings of the National Academy of Sciences.
[47] Omid C Farokhzad,et al. Targeted polymeric therapeutic nanoparticles: design, development and clinical translation. , 2012, Chemical Society reviews.